Ignite Creation Date:
2024-05-06 @ 12:24 AM
Last Modification Date:
2024-10-26 @ 10:49 AM
Study NCT ID:
NCT01566149
Status:
COMPLETED
Last Update Posted:
2024-05-24
First Post:
2012-03-27
Brief Title:
Study of Mometasone FuroateFormoterol Fumarate MFF Metered Dose Inhaler MDI in Adolescents Adults With Persistent Asthma P08212
Sponsor:
Organon and Co
Organization:
Organon and Co
Study Overview
Official Title:
An Open-Label Study to Assess the Safety and Tolerability of Zenhale a Fixed-Dose Combination of Mometasone FuroateFormoterol Fumarate Delivered by Metered Dose Inhaler in 40 Subjects With Persistent Asthma Protocol No 206-00 P08212
Status:
COMPLETED
Status Verified Date:
2022-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assess the safety tolerability effectiveness of 2 strengths of Mometasone FuroateFormoterol Fumarate MFF Metered Dose Inhaler MDI in the treatment of persistent asthma in adults adolescents
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| MK-0887A-206 | OTHER | Merck Study ID | None |